The assessment of NT-proBNP plays a central role in the stratification and management of cardiopulmonary risk in COPD patients, as also stated by a recent international multidisciplinary consensus on this topic [38]. This evidence concerns the gene NPPB and chronic obstructive pulmonary disease.